BRAF and neoplasm: As shown in Table 1, the results of the analyses showed that there were significant differences in T stage (p = 0.001), N stage (p = 0.03), pathologic stage (p = 0.003), residual tumour (p = 0.023), histologic type (p = 0.003), race (p = 0.025), extrathyroidal extension (p<0.001), and BRAF status (p = 0.019) in the TCGA cohort Table 1.